BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12135541)

  • 41. Impaired Expression of GABA Signaling Components in the Alzheimer's Disease Middle Temporal Gyrus.
    Govindpani K; Turner C; Waldvogel HJ; Faull RLM; Kwakowsky A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of the GABAergic neuronal system of the retina and superior colliculus in streptozotocin-induced diabetic rat.
    Honda M; Inoue M; Okada Y; Yamamoto M
    Kobe J Med Sci; 1998 Feb; 44(1):1-8. PubMed ID: 9846053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer brain metastases: evidence for neuronal-like adaptation in a 'breast-to-brain' transition?
    Van Swearingen AE; Siegel MB; Anders CK
    Breast Cancer Res; 2014 May; 16(3):304. PubMed ID: 25679873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gabaergic signaling mediates the morphological organization of astrocytes in the adult rat forebrain.
    Runquist M; Alonso G
    Glia; 2003 Jan; 41(2):137-51. PubMed ID: 12509804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonism of the enhanced susceptibility to audiogenic seizures during alcohol withdrawal in the rat by gamma-aminobutyric acid (GABA) and "GABA-mimetic" agents.
    Cooper BR; Viik K; Ferris RM; White HL
    J Pharmacol Exp Ther; 1979 Jun; 209(3):396-403. PubMed ID: 220408
    [No Abstract]   [Full Text] [Related]  

  • 46. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models.
    Reynolds GP; Abdul-Monim Z; Neill JC; Zhang ZJ
    Neurotox Res; 2004; 6(1):57-61. PubMed ID: 15184106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection.
    Ruzicka WB; Zhubi A; Veldic M; Grayson DR; Costa E; Guidotti A
    Mol Psychiatry; 2007 Apr; 12(4):385-97. PubMed ID: 17264840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
    Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participation of GABA/benzodiazepine receptor system in the adrenal chromaffin cell function.
    Guidotti A; Hanbauer I
    Adv Biochem Psychopharmacol; 1986; 42():165-72. PubMed ID: 3020895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of serotonin on the hypothalamic-pituitary GABAergic system.
    Afione S; Duvilanski B; Seilicovich A; Lasaga M; Díaz MC; Debeljuk L
    Brain Res Bull; 1990 Aug; 25(2):245-9. PubMed ID: 2224538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus.
    Wierońska JM; Brański P; Siwek A; Dybala M; Nowak G; Pilc A
    Brain Res; 2010 Jun; 1334():12-24. PubMed ID: 20353761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lead, GABA, and seizures: effects of subencephalopathic lead exposure on seizure sensitivity and GABAergic function.
    Silbergeld EK; Miller LP; Kennedy S; Eng N
    Environ Res; 1979 Aug; 19(2):371-82. PubMed ID: 227673
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of 5 days reserpine treatment on the cerebellar GABAergic system.
    Reggio A; Giammona G; Patti F; Condorelli DF; Rampello L; Nicoletti F; Canonico PL; Di Giorgio RM
    Acta Neurol (Napoli); 1981 Oct; 3(5):687-9. PubMed ID: 7315566
    [No Abstract]   [Full Text] [Related]  

  • 55. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia.
    Tooney PA; Chahl LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):273-8. PubMed ID: 14751422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction.
    Liu S; Bubar MJ; Lanfranco MF; Hillman GR; Cunningham KA
    Neuroscience; 2007 Jun; 146(4):1677-88. PubMed ID: 17467185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Schizophrenia and cortical GABA neurotransmission].
    Hashimoto T; Matsubara T; Lewis DA
    Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphological development and maturation of the GABAergic synapses in the mouse cerebellar granular layer.
    Takayama C; Inoue Y
    Brain Res Dev Brain Res; 2004 Jun; 150(2):177-90. PubMed ID: 15158081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3-fluoro-GABA enantiomers: exploring the conformation of GABA binding to GABAA receptors and GABA aminotransferase.
    O'Hagan D
    Future Med Chem; 2011 Feb; 3(2):189-95. PubMed ID: 21428814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propionate enters GABAergic neurons, inhibits GABA transaminase, causes GABA accumulation and lethargy in a model of propionic acidemia.
    Morland C; Frøland AS; Pettersen MN; Storm-Mathisen J; Gundersen V; Rise F; Hassel B
    Biochem J; 2018 Feb; 475(4):749-758. PubMed ID: 29339464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.